Prognostic factors and early predictability of sustained viral response with peginterferon alfa-2a (40KD)-Reference-Cited by-同舟云学术

Prognostic factors and early predictability of sustained viral response with peginterferon alfa-2a (40KD)

Published:2002-10 Issue:4 Volume:37 Page:500-506
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Lee Samuel S,Heathcote E.Jenny,Reddy K.Rajender,Zeuzem Stefan,Fried Michael W,Wright Teresa L,Pockros Paul J,Häussinger Dieter,Smith Coleman I,Lin Amy,Pappas Stephen C

Funder

F. Hoffmann-La Roche

Publisher

Elsevier BV

Subject

Hepatology

Reference28 articles.

1. Early predictors of response to treatment in patients with chronic hepatitis C;Civeira;J Hepatol,1999

2. Efficacy of interferon alfa therapy in chronic hepatitis C patients depends primarily on hepatitis C virus RNA level;Yamada;Hepatology,1995

3. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C;Martinot-Peignoux;Hepatology,1995

4. Serum hepatitis C virus RNA level as a predictor of subsequent response to interferon-α therapy in Japanese patients with chronic hepatitis C;Orito;J Med Virol,1994

5. Is an “a la carte” combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C?;Poynard;Hepatology,2000

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic, renal, and hematological changes in chronic hepatitis C patients achieving rapid virologic response after 12 weeks of direct-acting antiviral treatment: A prospective cohort study;PLOS ONE;2023-09-01

2. Liver stiffness measurements and FIB-4 are predictors of response to sofosbuvir-based treatment regimens in 7256 chronic HCV patients;Expert Review of Gastroenterology & Hepatology;2019-08-16

3. Efficacy of regimens containing pegylated interferon and ribavirin in the treatment of chronic hepatitis C: A retrospective overview;European Journal of Therapeutics;2018-01-04

4. Evaluation of the Performance Characteristics of an In-House One Step TaqMan Real Time-Polymerase Chain Reaction Assay for Detection and Quantification of Hepatitis C Virus;Jundishapur Journal of Microbiology;2017-02-06

5. Sustained virologic response achieved after curative treatment of hepatitis C virus-related hepatocellular carcinoma as an independent prognostic factor;Journal of Gastroenterology and Hepatology;2015-06-10